Jean Pierre Villafuerte Demera

Jean Pierre Villafuerte Demera

Auto-generated profile, based on publicly available information

Jean Pierre Villafuerte Demera

Universidad de Cuenca, Ecuador

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in Sapienza: International Journal of Interdisciplinary Studies
Verified
Journal Article
Open access
PDF file
JMJefferson Vicente Urvina Muñoz
Jefferson Vicente Urvina Muñoz
ELErika Alejandra Zúñiga San Lucas
Erika Alejandra Zúñiga San Lucas
NVNey Asdrubal Macias Valdez
Ney Asdrubal Macias Valdez
JVJean Pierre Villafuerte
Jean Pierre Villafuerte
CRCristhian Andrés Arroba Riofrio
Cristhian Andrés Arroba Riofrio
Background. Omics technologies, such as genomics, proteomics, metabolomics, and Transcriptomics are being used for identifying biomarkers. These biomarkers are unraveling the molecular mechanisms underlying type 2 diabetes mellitus (T2DM), which can help to promote more personalized treatment strategies and advance our understanding of disease pathogenesis. Omics approaches enable the examination of genetic, protein, metabolic, and gene expression profiles more comprehensively while offering insights into T2DM risk, progression, and potential therapeutic targets. Methods: This review follows a systematic methodology, aimed at evaluating omics technology’s role in diabetes research. Utilizing literature searches, we got an initial pool of 257 studies with a rigorous selection process and narrowed the selection to 10 high-quality studies. Our methodology approach ensured the inclusion of relevant, peer-reviewed articles that contribute significantly to understanding the application of omics technologies in predicting biomarkers for type 2 diabetes. Results: The systematic review identifies ten high-quality studies illuminating substantial omics technology’s role in advancing our understanding of type 2 diabetes (T2D). Collectively, these studies demonstrate how genomics, proteomics, metagenomics, metabolomics, and Transcriptomics have uncovered novel biomarkers and molecular pathways for T2D. Our findings underscore all the omics potentials specifically for developing predictive biomarkers, enhancing diagnostics, and tailoring personalized treatment strategies. Genetic variations, metabolic alterations, and protein and RNA expression profiles were highlighted as key areas where omics technologies offer insights into the pathophysiology and management of T2D.

2 May 2024 in International Journal of Medical Science and Dental Health
Verified
Journal Article
Closed access
BPBolívar Leonardo Saquinga Pujos
Bolívar Leonardo Saquinga Pujos
SHSantiago Israel Cárdenas Herrera
Santiago Israel Cárdenas Herrera
DJDaniela Geomar Salazar Jara
Daniela Geomar Salazar Jara
ATAndrés Geovanny Puchi Timbe
Andrés Geovanny Puchi Timbe
JDJean Pierre Villafuerte Demera
Jean Pierre Villafuerte Demera
MLMishelle Estefania Garcés López
Mishelle Estefania Garcés López

21 May 2024 in International Journal of Medical Science and Dental Health
Verified
Journal Article
Closed access
ATAlexander Gerardo Segovia Tapia
Alexander Gerardo Segovia Tapia
GCGabriela Racines Coba
Gabriela Racines Coba
JDJean Pierre Villafuerte Demera
Jean Pierre Villafuerte Demera
LFLaura Daniela Sosa Fierro
Laura Daniela Sosa Fierro
DVDoménica Villacís Vásquez
Doménica Villacís Vásquez
RCRomán Rolando Lima Cajas
Román Rolando Lima Cajas

16 March 2024 in International Journal of Research in Medical Sciences
Verified
Journal Article
Open access
PDF file
MVMiguel Andrés Irua Veloz
Miguel Andrés Irua Veloz
LPLeslie Dayanna Rivera Pinto
Leslie Dayanna Rivera Pinto
JPJuan Carlos Navarrete Pérez
Juan Carlos Navarrete Pérez
AMAndrea Gabriela Parada Marín
Andrea Gabriela Parada Marín
HMHenry Paúl Velasco Molina
Henry Paúl Velasco Molina
JVJean Pierre Villafuerte
Jean Pierre Villafuerte
Obesity is a worldwide epidemic, and current weight loss strategies frequently do not effectively tackle the problem. Bariatric surgery effectively addresses this issue. A systematic research study was done to investigate minimally invasive bariatric operations, using 32 studies from a pool of 2,118 data. Bariatric surgery was found to greatly assist in weight reduction and enhance general health results. Procedures such as gastric balloon, gastric banding, and gastric bypass can decrease the weight of obese people and alleviate associated health conditions. Sleeve gastrectomy is highly successful and yields favorable long-term results. The procedure used relies on the patient's health and the surgeon's discretion. The primary risk factor is the recurrence of weight or the need for revision surgery. Ultimately, bariatric procedures provide weight loss and long-term health benefits, but it is important to acknowledge the associated surgical risks. Immediate dangers include of blood clotting, intestine blockage, bleeding, infections, abdominal pain, nausea, heartburn, vomiting, ulcers, and other issues associated with surgery. Long-term consequences include of dumping syndrome, starvation, and weight regain.